Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.49 |
| ▸ | STAT1 | P42224 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8466680 | 0.95 | STAT3 (0.44) | STAT3STAT1 | |
| SCHEMBL28533125 | 0.89 | STAT3 (0.41) | STAT3STAT1 | |
| SCHEMBL8473510 | 0.85 | STAT3 (0.45) | STAT3STAT1 | |
| SCHEMBL6747972 | 0.83 | STAT3 (0.43) | STAT3STAT1 | |
| SCHEMBL4585422 | 0.81 | STAT3 (0.47) | STAT3STAT1 | |
| SCHEMBL28535234 | 0.81 | STAT3 (0.36) | STAT3STAT1 | |
| SCHEMBL8001501 | 0.79 | TERT (0.37) | — | |
| SCHEMBL8466676 | 0.78 | STAT3 (0.36) | STAT3STAT1 | |
| SCHEMBL51570 | 0.78 | STAT3 (0.59) | STAT3STAT1 | |
| SCHEMBL8677261 | 0.77 | STAT3 (0.37) | STAT3STAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240083920-A1 | LOW MOLECULAR WEIGHT CORROLE COMPOSITIONS | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD (IL) | 2024-03-14 | — | — | US | disclosed |
| EP-4277906-A1 | LOW MOLECULAR WEIGHT CORROLE COMPOSITIONS | Technion Research & Development Foundation Ltd. (IL) | 2023-11-22 | — | — | EP | disclosed |
| WO-2022153294-A1 | LOW MOLECULAR WEIGHT CORROLE COMPOSITIONS | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD (IL) | 2022-07-21 | — | — | WO | disclosed |
| US-10450322-B2 | Low molecular weight derivatives of carboxamide halogenated porphyrins, namely chlorins and bacteriochlorins, and their applications thereof | LUZITIN, S.A. (PT) | 2019-10-22 | — | — | US | disclosed |
| EP-3292129-B1 | LOW MOLECULAR WEIGHT HALOGENATED PORPHYRINE CARBOXAMIDE CHLORIN AND BACTERIOCHLORIN DERIVATIVES FOR USE IN PHOTODYNAMIC THERAPY FOR TREATING CANCER | LUZITIN S A (PT) | 2019-03-27 | — | — | EP | disclosed |
| US-20180282344-A1 | LOW MOLECULAR WEIGHT DERIVATIVES OF CARBOXAMIDE HALOGENATED PORPHYRINS, NAMELY CHLORINS AND BACTERIOCHLORINS, AND THEIR APPLICATIONS THEREOF | LUZITIN, S.A. (PT) | 2018-10-04 | — | — | US | disclosed |
| US-5990363-A | Method for oxidizing alkanes using novel porphyrins synthesized from dipyrromethanes and aldehydes | SUN COMPANY, INC. (US) | 1999-11-23 | — | — | US | disclosed |
| US-5760217-A | Porphyrins and their synthesis from dipyrromethanes and aldehydes | SUN COMPANY, INC. (US) | 1998-06-02 | — | — | US | disclosed |
| US-5723677-A | Method for hydroperoxide decomposition using novel porphyrins synthesized from dipyrromethanes and aldehydes | SUN COMPANY, INC. (R&M) (US) | 1998-03-03 | — | — | US | disclosed |
| US-5571908-A | Porphyrins | SUN COMPANY, INC. (R&M) (US) | 1996-11-05 | — | — | US | disclosed |
| EP-0665056-A2 | Method for oxidizing alkanes using halocarbyl-substituted porphyrins synthesized from meso-halocarbyl-dipyrromethanes and aldehydes | SUN COMPANY, INC. (R&M) (US) | 1995-08-02 | — | — | EP | disclosed |
| EP-0665230-A2 | Halocarbyl-substituted porphyrins and their synthesis from meso-halocarbyl-dipyrromethanes and aldehydes | SUN COMPANY, INC. (R&M) (US) | 1995-08-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10450322-B2 | Low molecular weight derivatives of carboxamide halogenated porphyrins, namely chlorins and bacteriochlorins, and their applications thereof | CRY1, PPIA, PPOX | STAT3 361/4885STAT1 833/4885 |
| US-20180282344-A1 | LOW MOLECULAR WEIGHT DERIVATIVES OF CARBOXAMIDE HALOGENATED PORPHYRINS, NAMELY CHLORINS AND BACTERIOCHLORINS, AND THEIR APPLICATIONS THEREOF | CRY1, PPIA, PPOX | STAT3 361/4885STAT1 833/4885 |
| US-20240083920-A1 | LOW MOLECULAR WEIGHT CORROLE COMPOSITIONS | CA13, CA11, IGFBP3 | STAT3 2579/4885STAT1 4091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.